<DOC>
	<DOC>NCT00286351</DOC>
	<brief_summary>Does a combination of Arimidex and Zoladex make endometriomas shrink and how is the following IVF outcome</brief_summary>
	<brief_title>Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<criteria>Endometrioma(s)with a size of 2070 mm, persisted for at least 3 cycles Couples with indication and wish for IVF/ICSI Age of women: 2040 years Regular menstrual cycle within normal range (2135 days) Body Mass Index (BMI): 1830 kg/m2 History with osteoporosis, liver, kidney or heart disease or thromboembolic disease Treatment of endometriosis with GnRH agonist during the last 3 month</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>